T36.6X2 Poisoning by rifampicins, intentional self-harm

Name of the Condition

• Poisoning by rifampicins, intentional self-harm

Summary

This condition describes intentional self-harm involving rifampicins, a class of antibiotics. It includes cases where deliberate exposure to rifampicins leads to harmful effects. Documentation should specify the intentional nature of the event and encounter details to guide accurate coding.

Causes

Intentional self-harm may result from deliberate overdose or exposure to rifampicins. This can occur due to suicidal intent, self-inflicted injury, or intentional misuse of the drug. Adverse effects may stem from toxic reactions or cumulative toxicity at supratherapeutic doses.

Risk Factors

• Prior history of mental health conditions or suicidal ideation.
• Access to rifampicins without supervision.
• Substance use disorders increasing self-harm risks.
• Social or environmental stressors contributing to intentional harm.
• Lack of support systems or mental health resources.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea.
• Hepatic: Jaundice, hepatotoxicity, elevated liver enzymes.
• Systemic: Fever, hypotension, or organ dysfunction.
• Neurological: Dizziness, confusion, or seizures in severe cases.
• Allergic: Rash, urticaria, or anaphylaxis.

Diagnosis

Evaluation includes patient history of intentional rifampicin exposure, clinical assessment of symptoms, and laboratory tests (e.g., liver function, drug levels). Toxicology screening may confirm exposure. Documentation must clarify the intentional nature of the event.

Treatment Options

Management focuses on stabilizing the patient, decontamination (if appropriate), and supportive care. Specific treatments may include activated charcoal, antidotes (if available), or organ support. Psychiatric evaluation and intervention are critical for intentional self-harm cases.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of intervention, and underlying health. Early treatment improves outcomes. Follow-up includes monitoring for delayed toxicity and addressing mental health needs. Long-term care may involve therapy or medication management.

Complications

• Severe hepatotoxicity or liver failure.
• Renal impairment or failure.
• Neurological damage (e.g., seizures, coma).
• Allergic reactions or anaphylaxis.
• Psychiatric sequelae or recurrent self-harm.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Mental health support and crisis intervention resources.
• Patient education on medication safety and self-harm risks.
• Regular psychiatric evaluations for at-risk individuals.
• Collaboration with healthcare providers for medication management.

When to Seek Professional Help

Seek immediate medical attention for suspected intentional self-harm, especially with symptoms like severe nausea, abdominal pain, jaundice, or altered mental status. Contact emergency services or a healthcare provider promptly.

Tips for Medical Coders

Document the intentional nature of the event and encounter details (e.g., initial, subsequent) to ensure accurate coding. Specify the type of rifampicin and any contributing factors (e.g., dose, route) to support code assignment.